Commerzbank has spent the past week confirming it can hit its full-year profit target of at least €3.4 billion, but the stock’s next real test comes from Brussels rather than Frankfurt. Reuters reported on Monday that the European Commission is expected to clear UniCredit’s takeover of the German lender without conditions, with a decision due by 16 November — the first of two regulatory gates that will shape the coming weeks.
UniCredit said the same day that it anticipates the remaining outstanding approvals by the end of November. Should that timetable hold, CEO Andrea Orcel intends to move straight to convening an extraordinary general meeting of Commerzbank shareholders to elect new supervisory board members. That step is explicitly conditional on completion of the deal.
Nine-Month Numbers Back the Standalone Case
The operational backdrop lends weight to the bull case. For the first nine months of 2026, Commerzbank posted an operating result of €4.04 billion and a net result of €2.67 billion. Alongside the confirmed annual profit goal, the bank adjusted its net interest income expectation to around €8.5 billion.
Momentum improved further in the third quarter, when net profit after tax and minorities climbed 45% to €859 million, as reported roughly a week ago. Management has also said a transaction with UniCredit could create value, and confirmed that preparations for a consolidation have begun.
Two Analysts Trim Their Targets
Not everyone is willing to underwrite the takeover story at current levels. On 5 November — the same day the nine-month figures landed — DZ Bank cut Commerzbank from “Buy” to “Hold” and lowered its fair value to €40 from €46. RBC also revised its view that day, reducing its price target to €39 from €41 while keeping a “Sector Perform” rating; the quarterly results prompted the rework. At €39.44, the stock now trades above RBC’s target.
Should investors sell immediately? Or is it worth buying Commerzbank?
Those downgrades form a genuine counterweight to takeover optimism. Any re-rating from here would need to be earned either through procedural progress or through convincingly delivered results.
What Investors Are Actually Weighing
Two considerations now sit side by side. A smooth approval process would reinforce the takeover narrative and shift attention toward completion and the planned supervisory board vote. A delay, by contrast, would demand more patience and push the standalone valuation of Commerzbank back to the fore — at which point earnings quality and target delivery would have to carry the stock on their own.
The 16 November Commission deadline is the nearest concrete catalyst. After that, the question becomes whether UniCredit’s end-November expectation for the remaining approvals survives contact with reality. Those two checkpoints will determine how much weight the takeover premium deserves — and how much rests on the bank’s own profit engine.
Ad
Commerzbank Stock: Buy or Sell?! New Commerzbank Analysis from November 11 delivers the answer:
The latest Commerzbank figures speak for themselves: Urgent action needed for Commerzbank investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 11.
Commerzbank: Buy or sell? Read more here...
